← FDA Drug Approvals (Drugs@FDA)

CEFIXIME

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AJENAT PHARMS · Approved 2017-02-06

Drug application

FDA Application #

ANDA206939

Application type

Abbreviated New Drug Application (Generic)

Brand name

CEFIXIME

Generic name

Cefixime

Active ingredients

CEFIXIME

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

AJENAT PHARMS

First approval

2017-02-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown